Document Detail


VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.
MedLine Citation:
PMID:  19965582     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our previous work indicated that apolipoprotein (apo) E4 assumes a more expanded conformation in the postprandial period. The postprandial state is characterized by increased VLDL lipolysis. In this article, we tested the hypothesis that VLDL lipolysis products increase VLDL particle fluidity, which mediates expansion of apoE4 on the VLDL particle. Plasma from healthy subjects was collected before and after a moderately high-fat meal and incubated with nitroxyl-spin labeled apoE. ApoE conformation was examined by electron paramagnetic resonance spectroscopy using targeted spin probes on cysteines introduced in the N-terminal (S76C) and C-terminal (A241C) domains. Further, we synthesized a novel nitroxyl spin-labeled cholesterol analog, which gave insight into lipoprotein particle fluidity. Our data revealed that the order of lipoprotein fluidity was HDL approximately LDL<VLDL<VLDL+lipoprotein lipase. Moreover, the conformation of apoE4 depended on the lipoprotein fraction: VLDL-associated apoE4 had a more linear conformation than apoE4 associated with LDL or HDL. Further, by changing VLDL fluidity, VLDL lipolysis products significantly altered apoE4 into a more expanded conformation. Our studies indicate that after every meal, VLDL fluidity is increased causing apoE4 associated with VLDL to assume a more expanded conformation, potentially enhancing the pathogenicity of apoE4 in vascular tissue.
Authors:
Sarada D Tetali; Madhu S Budamagunta; Catalina Simion; Laura J den Hartigh; Tamás Kálai; Kálmán Hideg; Danny M Hatters; Karl H Weisgraber; John C Voss; John C Rutledge
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-12-03
Journal Detail:
Title:  Journal of lipid research     Volume:  51     ISSN:  0022-2275     ISO Abbreviation:  J. Lipid Res.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-12     Completed Date:  2010-08-17     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  0376606     Medline TA:  J Lipid Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1273-83     Citation Subset:  IM    
Affiliation:
Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad 500 046, India. sdtsl@uohyd.ernet.in
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoprotein E3 / chemistry
Apolipoprotein E4 / blood,  chemistry*,  metabolism*
Electron Spin Resonance Spectroscopy
Humans
Lipolysis*
Lipoproteins, HDL / metabolism
Lipoproteins, VLDL / metabolism*
Models, Molecular
Peptide Fragments / chemistry,  metabolism
Postprandial Period
Protein Structure, Tertiary
Vascular Diseases / metabolism
Grant Support
ID/Acronym/Agency:
C06 RR-12088-01/RR/NCRR NIH HHS; HL-55667/HL/NHLBI NIH HHS; HL-HL71488/HL/NHLBI NIH HHS; R01 AG 028793/AG/NIA NIH HHS; R01 AG029246/AG/NIA NIH HHS; R01 AG029246-01A1/AG/NIA NIH HHS; R01 AG029246-05/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoprotein E3; 0/Apolipoprotein E4; 0/Lipoproteins, HDL; 0/Lipoproteins, VLDL; 0/Peptide Fragments
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New insights on the protein-ligand interaction differences between the two primary cellular retinol ...
Next Document:  Identification of atypical ether-linked glycerophospholipid species in macrophages by mass spectrome...